Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 35Ovarian Neoplasms 31Endometrial Neoplasms 13Uterine Cervical Dysplasia 10Papillomavirus Infections 9Breast Neoplasms 9Uterine Neoplasms 7Ovarian Cysts 6Lung Neoplasms 6Stomach Neoplasms 4Neoplasms 4Esophageal Neoplasms 4Carcinoma, Ovarian Epithelial 4Polycystic Ovary Syndrome 3Ovarian Hyperstimulation Syndrome 3Liver Neoplasms 3Leiomyoma 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Vomiting 2Uterine Diseases 2Urinary Bladder Neoplasms 2Tobacco Use Disorder 2Squamous Intraepithelial Lesions 2Small Cell Lung Carcinoma 2Recurrence 2Peritoneal Neoplasms 2Pancreatic Neoplasms 2

Interventions

human papillomavirus vaccine, L1 type 16, 18 1adacel 1Tetanus Toxoid 1Human Papillomavirus Recombinant Vaccine nonavalent 1Diphtheria-Tetanus-acellular Pertussis Vaccines 1Diphtheria Toxoid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Human Papillomavirus-Related Cervical Carcinoma × Gynecologic × Clear all
NCT05237947 2026-05-28

PRISMA

National Cancer Institute (NCI)

Phase 4 Active not recruiting
5,000 enrolled
Gynecologic

Human Papillomavirus-Related Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡